» Articles » PMID: 38673915

Experimental Models to Study Immune Dysfunction in the Pathogenesis of Parkinson's Disease

Abstract

Parkinson's disease (PD) is a chronic, age-related, progressive multisystem disease associated with neuroinflammation and immune dysfunction. This review discusses the methodological approaches used to study the changes in central and peripheral immunity in PD, the advantages and limitations of the techniques, and their applicability to humans. Although a single animal model cannot replicate all pathological features of the human disease, neuroinflammation is present in most animal models of PD and plays a critical role in understanding the involvement of the immune system (IS) in the pathogenesis of PD. The IS and its interactions with different cell types in the central nervous system (CNS) play an important role in the pathogenesis of PD. Even though culture models do not fully reflect the complexity of disease progression, they are limited in their ability to mimic long-term effects and need validation through in vivo studies. They are an indispensable tool for understanding the interplay between the IS and the pathogenesis of this disease. Understanding the immune-mediated mechanisms may lead to potential therapeutic targets for the treatment of PD. We believe that the development of methodological guidelines for experiments with animal models and PD patients is crucial to ensure the validity and consistency of the results.

Citing Articles

IMMUnity Unveiled: A Translational NETwork for tackling PARKinson's Disease - IMMUPARKNET.

Gugu M, Acharya S, Pira D, Poletti S, di Flora A, Saksida T Open Res Eur. 2025; 4:119.

PMID: 39911303 PMC: 11795026. DOI: 10.12688/openreseurope.17547.2.


Activation of Pedunculopontine Tegmental Nucleus Alleviates the Pain Induced by the Lesion of Midbrain Dopaminergic Neurons.

Zhang S, Zhang J, Yang Y, Zang W, Cao J Int J Mol Sci. 2024; 25(11).

PMID: 38891832 PMC: 11171649. DOI: 10.3390/ijms25115636.

References
1.
Perier C, Tieu K, Guegan C, Caspersen C, Jackson-Lewis V, Carelli V . Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage. Proc Natl Acad Sci U S A. 2005; 102(52):19126-31. PMC: 1323177. DOI: 10.1073/pnas.0508215102. View

2.
Han M, Nagele E, DeMarshall C, Acharya N, Nagele R . Diagnosis of Parkinson's disease based on disease-specific autoantibody profiles in human sera. PLoS One. 2012; 7(2):e32383. PMC: 3285212. DOI: 10.1371/journal.pone.0032383. View

3.
Samantaray S, Knaryan V, Shields D, Cox A, Haque A, Banik N . Inhibition of Calpain Activation Protects MPTP-Induced Nigral and Spinal Cord Neurodegeneration, Reduces Inflammation, and Improves Gait Dynamics in Mice. Mol Neurobiol. 2015; 52(2):1054-66. PMC: 4558265. DOI: 10.1007/s12035-015-9255-6. View

4.
Borghammer P . The brain-first vs. body-first model of Parkinson's disease with comparison to alternative models. J Neural Transm (Vienna). 2023; 130(6):737-753. DOI: 10.1007/s00702-023-02633-6. View

5.
Amor S, McNamara N, Gerrits E, Marzin M, Kooistra S, Miron V . White matter microglia heterogeneity in the CNS. Acta Neuropathol. 2021; 143(2):125-141. DOI: 10.1007/s00401-021-02389-x. View